ATE482726T1 - Neuartiges mittel zur freisetzung von wirkstoffen in dressings mit mindestens einer fettigen substanz - Google Patents

Neuartiges mittel zur freisetzung von wirkstoffen in dressings mit mindestens einer fettigen substanz

Info

Publication number
ATE482726T1
ATE482726T1 AT08805837T AT08805837T ATE482726T1 AT E482726 T1 ATE482726 T1 AT E482726T1 AT 08805837 T AT08805837 T AT 08805837T AT 08805837 T AT08805837 T AT 08805837T AT E482726 T1 ATE482726 T1 AT E482726T1
Authority
AT
Austria
Prior art keywords
dressings
active ingredients
fatty substance
releasing active
novel agent
Prior art date
Application number
AT08805837T
Other languages
English (en)
Inventor
Christelle Laurensou
Original Assignee
Urgo Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Urgo Lab filed Critical Urgo Lab
Application granted granted Critical
Publication of ATE482726T1 publication Critical patent/ATE482726T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/46—Deodorants or malodour counteractants, e.g. to inhibit the formation of ammonia or bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F13/02—Adhesive bandages or dressings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7016—Disaccharides, e.g. lactose, lactulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/20—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing organic materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/225—Mixtures of macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/44—Medicaments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0052—Mixtures of macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A61L26/0066—Medicaments; Biocides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/602—Type of release, e.g. controlled, sustained, slow

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Materials Engineering (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Anesthesiology (AREA)
  • Rheumatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Vascular Medicine (AREA)
  • Materials For Medical Uses (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Fats And Perfumes (AREA)
AT08805837T 2007-05-25 2008-05-23 Neuartiges mittel zur freisetzung von wirkstoffen in dressings mit mindestens einer fettigen substanz ATE482726T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0755272A FR2916356B1 (fr) 2007-05-25 2007-05-25 Nouvel agent permettant le relargage d'actifs dans des pansements contenant au moins un corps gras
PCT/FR2008/050893 WO2008149036A1 (fr) 2007-05-25 2008-05-23 Nouvel agent permettant le relargage d'actifs dans des pansements contenant au moins un corps gras

Publications (1)

Publication Number Publication Date
ATE482726T1 true ATE482726T1 (de) 2010-10-15

Family

ID=38834511

Family Applications (1)

Application Number Title Priority Date Filing Date
AT08805837T ATE482726T1 (de) 2007-05-25 2008-05-23 Neuartiges mittel zur freisetzung von wirkstoffen in dressings mit mindestens einer fettigen substanz

Country Status (19)

Country Link
US (1) US10500301B2 (de)
EP (1) EP2148703B1 (de)
JP (1) JP5290277B2 (de)
KR (1) KR101445900B1 (de)
CN (1) CN101678146B (de)
AT (1) ATE482726T1 (de)
AU (1) AU2008259661B2 (de)
BR (1) BRPI0811948B8 (de)
CA (1) CA2687731C (de)
DE (1) DE602008002835D1 (de)
DK (1) DK2148703T3 (de)
ES (1) ES2353851T3 (de)
FR (1) FR2916356B1 (de)
HK (1) HK1140972A1 (de)
MX (1) MX2009012743A (de)
PL (1) PL2148703T3 (de)
PT (1) PT2148703E (de)
RU (1) RU2448737C2 (de)
WO (1) WO2008149036A1 (de)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2916355B1 (fr) * 2007-05-25 2009-08-28 Urgo Soc Par Actions Simplifie Nouveau principe actif dans la cicatrisation et son utilisation
GB0808376D0 (en) 2008-05-08 2008-06-18 Bristol Myers Squibb Co Wound dressing
GB0817796D0 (en) 2008-09-29 2008-11-05 Convatec Inc wound dressing
GB201020236D0 (en) 2010-11-30 2011-01-12 Convatec Technologies Inc A composition for detecting biofilms on viable tissues
JP5965409B2 (ja) 2010-12-08 2016-08-03 コンバテック・テクノロジーズ・インコーポレイテッドＣｏｎｖａｔｅｃ Ｔｅｃｈｎｏｌｏｇｉｅｓ Ｉｎｃ 創傷滲出液を評価するための統合システム
JP6151186B2 (ja) 2010-12-08 2017-06-21 コンバテック・テクノロジーズ・インコーポレイテッドＣｏｎｖａｔｅｃ Ｔｅｃｈｎｏｌｏｇｉｅｓ Ｉｎｃ 創傷滲出液システム付属装置
FR2973223B1 (fr) * 2011-03-31 2013-04-19 Urgo Lab Pansement absorbant cicatrisant, ses utilisations pour les plaies chroniques
ES2489890T3 (es) 2011-05-19 2014-09-02 Lohmann & Rauscher Gmbh & Co. Kg Apósito esterilizado para heridas que comprende un elastómero tribloque sintético
PL2524705T3 (pl) * 2011-05-19 2014-12-31 Lohmann & Rauscher Gmbh & Co Kg Sterylne opatrunki ran zawierające syntetyczny elastomer trój-blokowy i hydrofobowy polimer biguanidyny
GB201115182D0 (en) 2011-09-02 2011-10-19 Trio Healthcare Ltd Skin contact material
GB2497406A (en) 2011-11-29 2013-06-12 Webtec Converting Llc Dressing with a perforated binder layer
GB201120693D0 (en) 2011-12-01 2012-01-11 Convatec Technologies Inc Wound dressing for use in vacuum therapy
FR2993182B1 (fr) * 2012-07-13 2014-10-17 Urgo Lab Pansement a liberation prolongee d'actifs
CA2895896A1 (en) 2012-12-20 2014-06-26 Convatec Technologies Inc. Processing of chemically modified cellulosic fibres
FR3037788B1 (fr) * 2015-06-29 2022-01-21 Urgo Lab Nouveau pansement absorbant antimicrobien
EP3435941B1 (de) 2016-03-30 2021-09-01 ConvaTec Technologies Inc. Nachweis von mikrobiellen infektionen in wunden
BR112018070238A2 (pt) 2016-03-30 2019-01-29 Acib Gmbh detecção de infecção microbiana em feridas
KR20190028467A (ko) 2016-07-08 2019-03-18 컨바텍 테크놀러지스 인크 체액 수집 장치
KR20190026858A (ko) 2016-07-08 2019-03-13 컨바텍 테크놀러지스 인크 가요성 부압 시스템
ES2912094T3 (es) 2016-07-08 2022-05-24 Convatec Technologies Inc Detección de flujo de fluidos
FR3068974B1 (fr) * 2017-07-12 2019-08-02 Urgo Recherche Innovation Et Developpement Pansement permettant la liberation controlee et prolongee d'actif
FR3068975B1 (fr) * 2017-07-12 2020-07-17 Urgo Recherche Innovation Et Developpement Composition pour pansement interface
CN108029925A (zh) * 2017-12-29 2018-05-15 常德金德新材料科技股份有限公司 一种基于短周期即食品的天然防霉材料及制备方法
CN109793919B (zh) * 2019-02-01 2022-01-14 明基材料（芜湖）有限公司 硫化氢缓释敷料及其制造方法
JP7511585B2 (ja) 2019-06-03 2024-07-05 コンバテック リミティド 病原体を破壊して封じ込めるための方法およびデバイス
US11331221B2 (en) 2019-12-27 2022-05-17 Convatec Limited Negative pressure wound dressing
US11771819B2 (en) 2019-12-27 2023-10-03 Convatec Limited Low profile filter devices suitable for use in negative pressure wound therapy systems

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2446793A (en) * 1945-07-04 1948-08-10 Wm S Merrell Co Substituted pyridinium and piperidinium compounds
US3929741A (en) * 1974-07-16 1975-12-30 Datascope Corp Hydrophilic acrylamido polymers
GB1576522A (en) 1977-05-24 1980-10-08 Colorplast International A S Sealing material for ostomy devices
DK147035C (da) * 1980-12-05 1984-09-03 Coloplast As Hudplade
US4912093A (en) * 1986-10-01 1990-03-27 Marion Laboratories, Inc. Use of synthetic sulfated saccharides to enhance wound healing
DK154747C (da) 1986-10-17 1989-05-08 Coloplast As Bandage med en hudvenlig, vandabsorberende klaebeskive der paa den ene flade er fast forbundet med en ikke-klaebende daekfilm og paa den anden med et aftageligt beskyttelsesdaekke
DK154806C (da) 1986-12-19 1989-06-26 Coloplast As Saarplejemiddel indeholdende et aktivt stof til fremme af saarbehandlingen og fremgangsmaade til fremstilling deraf
US5681579A (en) * 1993-03-22 1997-10-28 E.R. Squibb & Sons, Inc. Polymeric support wound dressing
US5968001A (en) 1996-05-14 1999-10-19 Bristol-Myers Squibb Company Wound dressings with leak prevention seal
FR2753380B1 (fr) 1996-09-16 1998-12-04 Lhd Lab Hygiene Dietetique Nouvelle masse adhesive hydrophile
FR2782086B1 (fr) * 1998-08-04 2000-12-01 Seppic Sa Nouveau latex epaississant a base d'acide 2-methyl 2-[(1-oxo 2-propenyl) amino] 1-propanesulfonique, copolymerise avec l'acrylate de (2-hydroxyethyle), procede de preparation et applications en cosmetique
JP4440466B2 (ja) * 1998-01-16 2010-03-24 ソシエテ・デクスプロワタシオン・デ・プロデュイ・プール・レ・アンデュストリー・シミック・セピック 濃縮ラテックス、製造プロセスおよび化粧品としての用途
FR2775903B1 (fr) 1998-03-12 2001-06-08 Lhd Lab Hygiene Dietetique Masse hydrocolloide a absorption accrue des les premieres heures d'utilisation
GB2341185A (en) 1998-09-07 2000-03-08 Polybiomed Ltd Polymerizable material and adhesive sheet material therefrom; dressings, electrodes and transdermal patches
FR2783412B1 (fr) * 1998-09-18 2000-12-15 Lhd Lab Hygiene Dietetique Compresse non adherente sterile
US5970515A (en) 1998-09-23 1999-10-26 Fishbaugh; Brenda B. Protective eyewear
US20020197302A1 (en) * 1998-11-12 2002-12-26 Cochrum Kent C. Hemostatic polymer useful for rapid blood coagulation and hemostasis
FR2806629B1 (fr) 2000-03-22 2003-01-24 Lhd Lab Hygiene Dietetique Compresse antiseptique
RU2276998C2 (ru) * 2001-05-01 2006-05-27 Институт Нефтехимического Синтеза Имени А.В. Топчиева Российской Академии Наук Гидрогелевые композиции
JP2003300856A (ja) * 2002-04-05 2003-10-21 Fancl Corp 化粧料組成物
KR100529209B1 (ko) * 2002-08-28 2005-11-17 한국과학기술연구원 세포 친화성이 향상된 생분해성의 조직 공학용 다공성고분자 지지체의 제조방법
WO2004103415A2 (en) * 2003-05-20 2004-12-02 Avery Dennison Corporation Multi-dressing system for managing skin wounds
US20060018852A1 (en) * 2003-08-22 2006-01-26 L'oreal Compositions containing topical active agents and pentylene glycol
WO2006007844A1 (en) 2004-07-16 2006-01-26 Coloplast A/S A wound care device
JP5102944B2 (ja) 2005-06-08 2012-12-19 ロート製薬株式会社 皮膚外用剤
JP2009040685A (ja) * 2005-11-04 2009-02-26 Toagosei Co Ltd 貼付剤
US7851633B2 (en) * 2006-06-09 2010-12-14 Beiersdorf Ag Piperidinium compounds and cosmetic compositions containing them
FR2916355B1 (fr) * 2007-05-25 2009-08-28 Urgo Soc Par Actions Simplifie Nouveau principe actif dans la cicatrisation et son utilisation

Also Published As

Publication number Publication date
EP2148703A1 (de) 2010-02-03
PL2148703T3 (pl) 2011-06-30
CA2687731A1 (fr) 2008-12-11
EP2148703B1 (de) 2010-09-29
RU2009147169A (ru) 2011-06-27
CA2687731C (fr) 2015-04-28
BRPI0811948A2 (pt) 2014-10-14
PT2148703E (pt) 2010-12-14
AU2008259661A1 (en) 2008-12-11
JP5290277B2 (ja) 2013-09-18
CN101678146B (zh) 2012-11-21
DK2148703T3 (da) 2011-01-10
DE602008002835D1 (de) 2010-11-11
RU2448737C2 (ru) 2012-04-27
KR20100016275A (ko) 2010-02-12
AU2008259661B2 (en) 2013-05-09
MX2009012743A (es) 2010-03-15
HK1140972A1 (en) 2010-10-29
CN101678146A (zh) 2010-03-24
KR101445900B1 (ko) 2014-09-29
BRPI0811948B1 (pt) 2018-07-17
BRPI0811948B8 (pt) 2021-06-22
FR2916356B1 (fr) 2009-08-28
US20100285129A1 (en) 2010-11-11
ES2353851T3 (es) 2011-03-07
WO2008149036A1 (fr) 2008-12-11
FR2916356A1 (fr) 2008-11-28
JP2010527977A (ja) 2010-08-19
US10500301B2 (en) 2019-12-10

Similar Documents

Publication Publication Date Title
ATE482726T1 (de) Neuartiges mittel zur freisetzung von wirkstoffen in dressings mit mindestens einer fettigen substanz
CL2018000818A1 (es) Composición de oligonucleotidos; métodos para alterar el empalme de un transcripto blanco; y uso de la composición para tratar distrofia muscular de duchenne.
CY1120888T1 (el) Διαδερμικες φαρμακευτικες συνθεσεις περιλαμβανοντας ενεργους παραγοντες
BRPI1007379B8 (pt) composições farmacêuticas para o tratamento ou prevenção de infecções orais por e. coli
BRPI0516857A (pt) dispositivos biomédicos que contêm copolìmeros de bloco anfifìlico
UY31209A1 (es) Uso de homo y copolimeros para la estabilización de formulaciones de principios activos
BRPI0514420A (pt) peptìdeo, variante do mesmo, ou um sal farmaceuticamente aceitável do mesmo, composição, uso de um peptìdeo ou de uma variante de peptìdeo, substrato, e, métodos de tratamento ou prevenção de um infecção microbiana, e de tratamento de uma ferida em um indivìduo
BRPI1012219B8 (pt) produto, substrato, composição farmacêutica, usos de um produto, e de um peptídeo antimicrobiano, métodos para tratar ou prevenir formação de biofilme em um ambiente, e, uso de uma cisteamina
EA201270803A1 (ru) Тиоацетатные соединения, композиции на их основе и способы их применения
PH12014501693A1 (en) Antimicrobial compositions comprising dgla, 15-ohepa and/or 15-hetre and methods of use thereof
WO2013178965A3 (fr) Principes actifs activateurs de la mitophagie des cellules cutanées et utilisation pour améliorer l'état de la peau
ATE456369T1 (de) Flibanserin zur behandlung von harninkontinenz und assoziierten erkrankungen
BRPI0909447A2 (pt) Composição, métodos para tratar um indivíduo humano ou animal em necessidade de tal tratamento e para matar ou inibir o crescimento de microrganismos suscetíveis, e, uso de uma composição
MX2010004613A (es) Composicion topica.
MX2009012742A (es) Ingrediente activo novedoso en cicatrizacion y uso del mismo.
BR112013004436A2 (pt) composições e usos de materiais com atividade microbicida alta e toxicidade baixa
BR112012007798A2 (pt) microcápsulas estáveis e composição para aplicação tópica e método para a preparação de microcápsulas
BR112014000542A2 (pt) composições de peroxidase eosinofílica e métodos de uso das mesmas
MX2019007572A (es) Composiciones que comprenden acido acetico y acido hipocloroso y metodos para tratar biopelicula.
HK1112721A1 (en) Tissue disruption treatment and composition for use thereof
NI201900063A (es) Amidas aromáticas de ácido carboxílico
BR112014026483A2 (pt) composição antimicrobiana, composição antimicrobiana bicomponente, pano de limpeza, método para desinfetar uma superfície e método para controlar esporos sobre uma superfície
BR112019003816A2 (pt) composição de tratamento de enxágue dos cabelos, método para tratamento de cabelos quimicamente danificados e uso de uma composição
DK1893248T3 (da) Filmdannende sammensætning
CL2008001280A1 (es) Composicion farmaceutica que comprende una sal de aminoacido n-halogenado; procedimiento de preparacion; y su uso como antimicrobiano.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 2148703

Country of ref document: EP